Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2725283 | 0.95 | TP53 (0.37) | TP53 | |
| SCHEMBL14937440 | 0.91 | — | — | |
| SCHEMBL14937957 | 0.84 | — | — | |
| SCHEMBL2555809 | 0.76 | FDPS (0.41) | — | |
| SCHEMBL11752969 | 0.74 | — | — | |
| SCHEMBL27723105 | 0.72 | TP53 (0.46) | TP53 | |
| SCHEMBL14938306 | 0.72 | FDPS (0.42) | — | |
| SCHEMBL23000969 | 0.70 | TP53 (0.44) | TP53 | |
| SCHEMBL5454180 | 0.70 | TP53 (0.44) | TP53 | |
| Ammonia Solution, Strong SCHEMBL28140587 | 0.70 | TP53 (0.44) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180346804-A1 | CROSSLINKED POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL AND LACTAM MOIETIES AND SULFONIC ACID/SULFONATE COMONOMERS, COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | HERCULES LLC | 2018-12-06 | — | — | US | claimed |
| EP-3377034-A1 | CROSSLINKED POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL AND LACTAM MOIETIES AND SULFONIC ACID/SULFONATE COMONOMERS, COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | Hercules LLC (US) | 2018-09-26 | — | — | EP | claimed |
| US-9493598-B2 | Polymers having acid and amide moieties, and uses thereof | ISP INVESTMENTS LLC (US) | 2016-11-15 | — | — | US | claimed |
| US-20130261275-A1 | NON-HOMOPOLYMERS EXHIBITING GAS HYDRATE INHIBITION, SALT TOLERANCE AND HIGH CLOUD POINT | ISP INVESTMENTS INC. (US) | 2013-10-03 | — | — | US | claimed |
| US-20130123147-A1 | POLYMERS HAVING ACID AND AMIDE MOIETIES, AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2013-05-16 | — | — | US | claimed |
| WO-2012054569-A2 | NON-HOMOPOLYMERS EXHIBITING GAS HYDRATE INHIBITION, SALT TOLERANCE AND HIGH CLOUD POINT | ISP INVESTMENTS INC. (US) | 2012-04-26 | — | — | WO | claimed |
| WO-2011130370-A1 | POLYMERS HAVING ACID AND AMIDE MOIETIES, AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2011-10-20 | — | — | WO | claimed |
| US-11001751-B2 | Crosslinked polymers derived from monomers having acryloyl and lactam moieties and sulfonic acid/sulfonate comonomers, compositions thereof, and applications thereof | HERCULES LLC (US) | 2021-05-11 | — | — | US | disclosed |
| US-20180346804-A1 | CROSSLINKED POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL AND LACTAM MOIETIES AND SULFONIC ACID/SULFONATE COMONOMERS, COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | HERCULES LLC | 2018-12-06 | — | — | US | disclosed |
| EP-3377034-A1 | CROSSLINKED POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL AND LACTAM MOIETIES AND SULFONIC ACID/SULFONATE COMONOMERS, COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | Hercules LLC (US) | 2018-09-26 | — | — | EP | disclosed |
| US-9493598-B2 | Polymers having acid and amide moieties, and uses thereof | ISP INVESTMENTS LLC (US) | 2016-11-15 | — | — | US | disclosed |
| US-20130123147-A1 | POLYMERS HAVING ACID AND AMIDE MOIETIES, AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2013-05-16 | — | — | US | disclosed |
| WO-2011130370-A1 | POLYMERS HAVING ACID AND AMIDE MOIETIES, AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2011-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11001751-B2 | Crosslinked polymers derived from monomers having acryloyl and lactam moieties and sulfonic acid/sulfonate comonomers, compositions thereof, and applications thereof | CAD, STS, COASY | TP53 2988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.